`By:
`
`Eric W. Dittmann
`Naveen Modi
`Paul Hastings LLP
`75 East 55th Street
`New York, NY 10022
`Telephone: (212) 318-6000
`Facsimile: (202) 319-4090
`Email: ericdittmann@paulhastings.com
` naveenmodi@paulhastings.com
`
`Paper No. ______
`
`
`Mark E. Waddell
`Loeb & Loeb LLP
`345 Park Avenue
`New York, NY 10154
`Telephone: (212) 407-4127
`Facsimile: (646) 619-4540
`Email: mwaddell@loeb.com
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`ACCORD HEALTHCARE, INC.,
`Petitioner
`
`v.
`
`HELSINN HEALTHCARE S.A. and
`ROCHE PALO ALTO LLC,
`Patent Owners
`
`
`
`
`
`
`
`
`Case PGR2014-00010
`Patent 8,598,219
`
`
`
`
`
`
`
`
`
`
`PATENT OWNERS’ MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`Helsinn Healthcare S.A. (“Helsinn”) and Roche Palo Alto LLC (“Roche”)
`
`Case PGR2014-00010
`Patent 8,598,219
`
`
`
`(collectively, “Patent Owners”), submit the following mandatory notices in
`
`connection with the above-identified proceeding.1
`
`I.
`
`
`Real Party-in-Interest
`
`Pursuant to 37 C.F.R. § 42.8(b)(1), the real parties-in-interest are Helsinn
`
`and Roche, the assignees of record for U.S. Patent No. 8,598,219 (“the ’219
`
`patent”).
`
`II. Related Matters
`Patent Owners identify the following matters that may be deemed related
`
`pursuant to 37 C.F.R. § 42.8(b)(2).
`
`A. U.S. Patent and Applications Related to the Patent-at-Issue
`The following patent and applications claim priority to the ’219 patent:
`
` U.S. Patent No. 8,729,094 (“the ’094 patent”)
`
` U.S. Application No. 13/901,830
`
` U.S. Application No. 13/902,299
`
` U.S. Application No. 14/070,981
`
`
`
`
`1 Powers of Attorney appointing lead and back-up counsel are being filed
`
`concurrently with these Notices.
`
`1
`
`
`
`Litigations Involving the Patent-at-Issue and/or Related Patents
`
`B.
`Patents claiming their earliest priority date to the same provisional
`
`Case No. PGR2014-00010
`Patent No. 8,598,219
`
`
`application, No. 60/444,351, as the ’219 patent, are at issue in one or more of the
`
`following cases:
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Laboratories, Ltd. et al.,
`
`Case No. 3-11-cv-03962 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Laboratories, Ltd. et al.,
`
`Case No. 3-11-cv-05579 (D.N.J.)2
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Laboratories, Ltd. et al.,
`
`Case No. 3-12-cv-02867 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Laboratories, Ltd. et al.,
`
`Case No. 3-13-cv-05815 (D.N.J.)3
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Laboratories, Ltd. et al.,
`
`Case No. 3-14-cv-04274 (D.N.J.)
`
`
`2 Patent Owners note that this case has been consolidated with Case
`
`No. 3-11-cv-3962.
`
`3 Patent Owners note that this case has been consolidated with Case
`
`No. 3-11-cv-3962.
`
`2
`
`
`
` Helsinn Healthcare S.A. et al. v. Aurobindo Pharma Ltd. et al.,
`
`Case No. PGR2014-00010
`Patent No. 8,598,219
`
`
`Case No. 1-13-cv-00688 (D. Del.)
`
` Helsinn Healthcare S.A. et al. v. Ben Venue Laboratories, Inc.,
`
`Case No. 1-13-cv-01612 (D. Del.)4
`
` Helsinn Healthcare S.A. et al. v. Accord Healthcare, Inc. et al.,
`
`Case No. 1-13-cv-02101 (D. Del.)5
`
` Helsinn Healthcare S.A. et al. v. Cipla Ltd. et al.,
`
`Case No. 1-14-cv-00427 (D. Del.)6
`
` Helsinn Healthcare S.A. et al. v. Mylan, Inc. et al.,
`
`Case No. 1-14-cv-00709 (D. Del.)
`
`III. Lead and Back-Up Counsel and Service Information
`In accordance with 37 C.F.R. §42.8(b)(3) and (b)(4), Patent Owners identify
`
`the following lead and back-up counsel and service information:
`
`4 Patent Owners note that this case has been consolidated with Case
`
`No. 1-13-cv-00688.
`
`5 Patent Owners note that this case has been consolidated with Case
`
`No. 1-13-cv-00688.
`
`6 Patent Owners note that this case has been consolidated with Case
`
`No. 1-13-cv-00688.
`
`3
`
`
`
`Lead Counsel
`Eric W. Dittmann (Reg. No. 51,188)
`
`Case No. PGR2014-00010
`Patent No. 8,598,219
`
`
`Back-Up Counsel
`Naveen Modi (Reg. No. 46,224)
`
`Paul Hastings LLP
`
`75 East 55th Street
`
`Paul Hastings LLP
`
`875 15th Street NW
`
`New York, NY 10022
`
`Washington, DC 20005
`
`Telephone: (212) 318-6000
`
`Telephone: (202) 551-1990
`
`Facsimile: (202) 319-4090
`
`Facsimile: (202) 551-0490
`
`Email: ericdittmann@paulhastings.com
`
`Email: naveenmodi@paulhastings.com
`
`Back-Up Counsel
`
`Back-Up Counsel
`
`Mark E. Waddell (Reg. No. 31,803)
`
`Thomas L. Irving (Reg. No. 28,619)
`
`Loeb & Loeb LLP
`
`345 Park Avenue
`
`New York, NY 10154
`
`Telephone: (212) 407-4127
`
`Facsimile: (646) 619-4540
`
`Email: mwaddell@loeb.com
`
`Dated: September 22, 2014
`
`Finnegan LLP
`
`901 New York Avenue, NW
`
`Washington, DC 20001-4413
`
`Telephone: (202) 408-4082
`
`Facsimile: (202) 408-4400
`
`Email: tom.irving@finnegan.com
`
`
`Respectfully submitted,
`
`By:
`
`
`/Eric W. Dittmann/
`Eric W. Dittmann (Reg. No. 51,188)
`Naveen Modi (Reg. No. 46,224)
`Mark E. Waddell (Reg. No. 31,803)
`Thomas L. Irving (Reg. No. 28,619)
`Counsel for Patent Owners
`
`4
`
`
`
`
`
`Certificate of Service
`
`Case PGR2014-00010
`Patent 8,598,219
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioner a true and correct copy of the foregoing Patent Owner’s
`
`Mandatory Notices Pursuant to 37 C.F.R. § 42.8 by electronic means on September
`
`22, 2014 at the following address of record:
`
`Michael J. Fink, Esq. (mfink@gbpatent.com)
`
`Paul A. Braier, Esq. (pbraier@gbpatent.com)
`
`Respectfully submitted,
`
`By:
`
`
`/Eric W. Dittmann/
`Eric W. Dittmann (Reg. No. 51,188)
`Naveen Modi (Reg. No. 46,224)
`Mark E. Waddell (Reg. No. 31,803)
`Thomas L. Irving (Reg. No. 28,619)
`Counsel for Patent Owners
`
`Dated: September 22, 2014



